Skip to main content
16 August 2026
08 August 2024

Cipla EU to invest EUR 3 million in Ethris to develop mRNA-based therapies

Cipla Limited announced that its wholly-owned subsidiary in United Kingdom, Cipla (EU) Limited will invest an additional EUR 3 million in Ethris GmbH (“Ethris”), a global leader in delivering mRNAs directly to the respiratory system. This additional investment through a convertible loan will accelerate Cipla’s partici…

31 July 2024

Merck Invests € 62 Million in New Quality Control Facility in, Germany

Merck, a leading science and technology company, announces an investment of € 62 million at its Darmstadt headquarters in a new quality control building for its Life Science business. The facility will bring together approximately 135 employees across several departments into one collaborative state-of-the-art space. …

23 July 2024

Vividion Therapeutics to Expand with New Global Research and Development Center

Vividion Therapeutics, Inc, a clinical stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders, announced it will expand its global innovation capabilities with a new research…

22 July 2024

Sanofi to Invest €400 Million in Expanding Hyderabad GCC, Aiming for 2600 Employees

Sanofi Healthcare India Pvt. Ltd. announces the expansion of its Global Capacity Centre (GCC) in Hyderabad, with plans to invest €400 million over the next six years, with €100 million by 2025. Over the next two years, this GCC (hub) will expand to host up to ~2600 employees, making it the largest of Sanofi’s four glo…

Page 32 of 57